Finance

Lists
ANTHEM:NSE
Anthem Biosciences Limited
₹959.00
+1.77%
(+16.65) 1D
Nov 9, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ANTHEM...
Open
₹949.00
High
₹989.10
Low
₹946.50
Mkt. cap
539.94B
Avg. vol.
415.58K
Volume
1.73M
Dividend
0.21%
Quarterly dividend
₹0.50
Ex-dividend date
Jun 25, 2026
P/E ratio
88.26
52-wk high
₹989.10
52-wk low
₹579.15
EPS
₹10.87
No. of employees
2K
Open
₹949.00
High
₹989.10
Low
₹946.50
Mkt. cap
539.94B
Avg. vol.
415.58K
Volume
1.73M
Dividend
0.21%
Quarterly dividend
₹0.50
Ex-dividend date
Jun 25, 2026
P/E ratio
88.26
52-wk high
₹989.10
52-wk low
₹579.15
EPS
₹10.87
No. of employees
2K
News stories
From web sources and news partners
About Anthem Biosciences Limited
CEO-
Employees2.28K
Founded2006
Headquarters-
SectorHealth Care
Industry-
Last report
Nov 4, 2026
Fiscal period
Q2 2027
₹3.72 / ₹3.50
+6.29%beat
Revenue / Est. (INR)
5.94B / 6.11B
-2.77%miss
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
4.23B
6.16B
4.18B
5.94B
Cost of goods sold
1.43B
2.57B
1.46B
1.85B
Cost of revenue
1.43B
2.57B
1.46B
1.85B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
704.79M
745.64M
788.36M
812.50M
Operating expense
1.58B
1.22B
1.51B
1.69B
Total operating expenses
3.00B
3.80B
2.98B
3.53B
Operating income
1.23B
2.36B
1.21B
2.41B
Other non operating income
335.30M
-1.05B
248.87M
588.97M
EBT including unusual items
1.30B
2.78B
1.45B
2.96B
EBT excluding unusual items
1.56B
2.67B
1.45B
2.96B
Income tax expense
376.57M
881.59M
246.40M
849.10M
Effective tax rate
28.86%
31.72%
17.04%
28.65%
Other operating expenses
528.85M
79.01M
426.16M
566.01M
Net income
928.17M
1.90B
1.20B
2.11B
Net profit margin
21.93%
30.81%
28.68%
35.60%
Earnings per share
1.96
-
2.11
3.72
Interest and investment income
-
792.70M
-
-
Interest expense
-3.52M
-15.47M
-8.87M
-33.10M
Net interest expenses
-3.52M
777.23M
-8.87M
-33.10M
Depreciation and amortization charges
345.33M
395.91M
299.87M
307.11M
EBITDA
1.45B
2.69B
1.54B
2.71B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps